Evidence map›Paper›PMID 41977358›Full record

ArticleInternational journal of molecular sciences2026

Differential Effects of Oleoyl Serine and HU-910 on Anxiety-like and Depression-like Behaviors in Male and Female WKY Rats.

Jenna Gellman, Natalia Zemliana, Yoni Loterstein, Elin Kachuki Dory, Devorah Matas, Gal Shoval, Eyal Sharon, Igor Koman, Gil Zalsman, Lee Koren and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jenna GellmanGonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel.ORCID 0009-0003-5074-6716
Natalia ZemlianaInstitute for Personalized and Translational Medicine, Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 4070000, Israel.ORCID 0000-0003-4037-4341
Yoni LotersteinGonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel.ORCID 0009-0006-3351-1706
Elin Kachuki DoryGonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel.
Devorah MatasFaculty of Life Sciences, Bar Ilan University, Ramat-Gan 5290002, Israel.
Gal ShovalGeha Mental Health Center, Petah Tiqva 49100, Israel.
Eyal SharonInstitute for Personalized and Translational Medicine, Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 4070000, Israel.
Igor KomanInstitute for Personalized and Translational Medicine, Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 4070000, Israel.
Gil ZalsmanGeha Mental Health Center, Petah Tiqva 49100, Israel.
Lee KorenGonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel.ORCID 0000-0002-7425-501X
Aron WellerGonda Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel.ORCID 0000-0002-0663-4384
Natalya M KoganInstitute for Personalized and Translational Medicine, Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 4070000, Israel.ORCID 0000-0002-6792-3841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of the endocannabinoid system (ECS) in the development of depression and anxiety is being actively studied, with evidence suggesting that elevation of ECS signaling can have anxiolytic and antidepressant properties. The current study explored the therapeutic potential of Oleoyl Serine (OS), an endocannabinoid-like lipid, and HU-910, a synthetic selective Cannabinoid type 2 (CB2) receptors agonist, in depression and anxiety, using both sexes of the depressive-like genetic model: Wistar Kyoto (WKY) rats. The aim was to investigate behavioral and molecular mechanisms associated with acute and sub-chronic intraperitoneal administration of these compounds. We showed that, in females, acutely administered OS yielded antidepressant-like and anxiolytic-like effects in the Forced Swim Test (FST) and Open Field Test (OFT), respectively. In males, OS yielded acute and sub-chronic anxiolytic-like effects. HU-910 yielded an acute anxiolytic-like effect in females and an acute antidepressant-like effect in males. Sub-chronic administration of imipramine (IMI), used as a positive control, yielded an antidepressant-like effect in both sexes but an anxiogenic-like effect in females. Sub-chronic administration of all the treatments increased hippocampal

Indexed as

Anti-Anxiety AgentsAnxietyBehavior, AnimalDepressionOleic AcidsAnimalsAntidepressive AgentsCyclohexanolsDisease Models, AnimalFemaleMaleRatsRats, Inbred WKYReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB23-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanolAnti-Anxiety AgentsAntidepressive AgentsCyclohexanolsOleic AcidsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2animal models of depressionendocannabinoid systemWistar-Kyoto rats

Identifiers

PMID41977358
PMCPMC13072787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.